Todd Yezefski, MD | Authors


Examining mCRC Chemotherapy Costs, Patient Outcomes in Washington vs British Columbia

June 12, 2018

Todd Yezefski, MD, a senior fellow in the Clinical Research Division at the Fred Hutchinson Cancer Research Center, discusses the results of a trial investigating cost and outcome differences in patients with metastatic colorectal cancer in the United States and Canada. Specifically, he looked at patients in Washington and British Columbia. This data was presented at the 2018 ASCO Annual Meeting.